AlphaQuest LLC Has $454,000 Holdings in Avanos Medical, Inc. $AVNS

AlphaQuest LLC grew its holdings in shares of Avanos Medical, Inc. (NYSE:AVNS) by 58.5% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 37,091 shares of the company’s stock after purchasing an additional 13,692 shares during the period. AlphaQuest LLC owned about 0.08% of Avanos Medical worth $454,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Tributary Capital Management LLC grew its position in shares of Avanos Medical by 10.0% during the 2nd quarter. Tributary Capital Management LLC now owns 810,720 shares of the company’s stock worth $9,923,000 after purchasing an additional 73,518 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in shares of Avanos Medical during the 2nd quarter worth approximately $192,000. Allianz Asset Management GmbH acquired a new position in shares of Avanos Medical during the 2nd quarter worth approximately $511,000. CWM LLC grew its position in shares of Avanos Medical by 2,882.2% during the 2nd quarter. CWM LLC now owns 24,275 shares of the company’s stock worth $297,000 after purchasing an additional 23,461 shares in the last quarter. Finally, Williams & Novak LLC grew its position in shares of Avanos Medical by 71.3% during the 2nd quarter. Williams & Novak LLC now owns 22,219 shares of the company’s stock worth $272,000 after purchasing an additional 9,250 shares in the last quarter. Institutional investors and hedge funds own 95.17% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Wall Street Zen lowered shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 9th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Avanos Medical in a report on Tuesday, October 14th. Finally, Zacks Research raised shares of Avanos Medical to a “hold” rating in a report on Tuesday, August 12th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Reduce”.

Insider Buying and Selling

In other Avanos Medical news, Director Gary Blackford purchased 40,000 shares of the company’s stock in a transaction dated Wednesday, August 13th. The stock was purchased at an average price of $10.99 per share, with a total value of $439,600.00. Following the completion of the purchase, the director owned 40,000 shares of the company’s stock, valued at approximately $439,600. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. 2.64% of the stock is currently owned by insiders.

Avanos Medical Price Performance

Shares of NYSE:AVNS opened at $11.40 on Thursday. The company has a market cap of $528.73 million, a price-to-earnings ratio of -1.13 and a beta of 1.15. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.64 and a quick ratio of 1.58. The firm has a 50 day simple moving average of $11.76 and a 200 day simple moving average of $11.96. Avanos Medical, Inc. has a one year low of $9.30 and a one year high of $21.27.

Avanos Medical (NYSE:AVNS) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.01). The company had revenue of $175.00 million during the quarter, compared to the consensus estimate of $165.50 million. Avanos Medical had a negative net margin of 66.89% and a positive return on equity of 6.16%. During the same period in the previous year, the company earned $0.34 EPS. Avanos Medical has set its FY 2025 guidance at 0.750-0.950 EPS. Research analysts predict that Avanos Medical, Inc. will post 1.32 earnings per share for the current fiscal year.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.